The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity

References

1. Balsinde J., Balboa M. A., Insel P. A., Dennis E. A. 1999; Regulation and inhibition of phospholipase A2. Annual Review of Pharmacology and Toxicology 39:175–189
   [Google Scholar]
2. Berns K. 1990; Parvovirus replication. Microbiological Reviews 54:316–329
   [Google Scholar]
3. Berns K. I., Giraud C. 1996; Biology of adeno-associated virus. Current Topics in Microbiology and Immunology 218:1–23
   [Google Scholar]
4. Dennis E. A. 1997; The growing phospholipase A2 superfamily of signal transduction enzymes. Trends in Biochemical Sciences 22:1–2
   [Google Scholar]
5. Dessen A. 2000; Phospholipase A₂ enzymes: structural diversity in lipid messenger metabolism. Structure with Folding & Design 8:R15–R22
   [Google Scholar]
6. Girod A., Ried M., Wobus C., Lahm H., Leike K., Kleinschmidt J., Deleage G., Hallek M. 1999; Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nature Medicine 5:1052–1056
   [Google Scholar]
7. Grimm D., Kern A., Pawlita M., Ferrari F., Samulski R., Kleinschmidt J. 1999; Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2. Gene Therapy 6:1322–1330
   [Google Scholar]
8. Hermonat P. L., Labow M. A., Wright R., Berns K. I., Muzyczka N. 1984; Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. Journal of Virology 51:329–339
   [Google Scholar]
9. Manjunath P., Soubeyrand S., Chandonnet L., Roberts K. D. 1994; Major proteins of bovine seminal plasma inhibit phospholipase A2. Biochemical Journal 303:121–128
   [Google Scholar]
10. Murakami M., Nakatani Y., Atsumi G., Inoue K., Kudo I. 1997; Regulatory functions of phospholipase A2. Critical Reviews in Immunology 17:225–283
    [Google Scholar]
11. Rabinowitz J. E., Samulski R. J. 2000; Building a better vector: the manipulation of AAV virions. Virology 278:301–308
    [Google Scholar]
12. Redemann B. E., Mendelson E., Carter B. J. 1989; Adeno-associated virus rep protein synthesis during productive infection. Journal of Virology 63:873–882
    [Google Scholar]
13. Ruffing M., Zentgraf H., Kleinschmidt J. A. 1992; Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. Journal of Virology 66:6922–6930
    [Google Scholar]
14. Tratschin J. D., Miller I. L., Carter B. J. 1984; Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. Journal of Virology 51:611–619
    [Google Scholar]
15. Trempe J. P., Mendelson E., Carter B. J. 1987; Characterization of adeno-associated virus rep proteins in human cells by antibodies raised against rep expressed in Escherichia coli . Virology 161:18–28
    [Google Scholar]
16. Wistuba A., Weger S., Kern A., Kleinschmidt J. A. 1995; Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins. Journal of Virology 69:5311–5319
    [Google Scholar]
17. Wistuba A., Kern A., Weger S., Grimm D., Kleinschmidt J. A. 1997; Subcellular compartmentalization of adeno-associated virus type 2 assembly. Journal of Virology 71:1341–1352
    [Google Scholar]
18. Zádori Z., Szelei J., Lacoste M.-C., Li Y., Gariépy S., Raymond P., Allaire M., Nabi I. R., Tijssen P. 2001; A viral phospholipase A2 is required for parvovirus infectivity. Developmental Cell 1:291–302
    [Google Scholar]